Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-12-30
2009-06-09
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S324000, C530S330000
Reexamination Certificate
active
07544665
ABSTRACT:
Methods for the solid phase synthesis of T-1249 peptides and peptide intermediates, in particular methods involving synthesizing T-1249 peptide intermediates at low loading factors to produce products having excellent purity and yield.
REFERENCES:
patent: 5464933 (1995-11-01), Bolognesi et al.
patent: 5656480 (1997-08-01), Wild et al.
patent: 6015881 (2000-01-01), Kang et al.
patent: 6281331 (2001-08-01), Kang et al.
patent: 6281335 (2001-08-01), do Couto et al.
patent: 6469136 (2002-10-01), Bray et al.
patent: 6479055 (2002-11-01), Bolognesi et al.
patent: 2004/0209999 (2004-10-01), Bohling et al.
patent: 2006/0276624 (2006-12-01), Khatri et al.
patent: 1 452 538 (2004-09-01), None
Albericio, F., (Jun. 2004) “Developments in Peptide and Amide Synthesis,” Current Opinion in Chemical Biology, vol. 8, No. 3, pp. 211-221.
Bruckdorfer, T., et al., (Feb. 2004) “From Production of Peptides in Milligram Amounts for Research to Multi-tons Quantities for Drugs of the Future,” Current Pharmaceutical Biotechnology, vol. 5, No. 1, pp. 29-43.
Riniker, et al., (1993) Tetrahedron Letters 49:9307-9320.
Lloyd-Williams, et al., (1993) Tetrahedron Letters 49:11065-11133.
Andersson, et al., (2000) Biopolymers 55:227-250.
Bray, B.L., (2003) Nature Rev., 2:587-593.
International Search Report for International Application No. PCT/EP2005/013852, mailed Jun. 19, 2006.
Han Yeun-Kwei
Hodges L. Mark
Johnston David A.
Khatri Hiralal N.
Buckwalter Brian L.
Roche Colorado Corporation
Tate Christopher R.
Teller Roy
LandOfFree
Synthesis using peptide intermediate fragments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthesis using peptide intermediate fragments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis using peptide intermediate fragments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4119673